These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7175700)

  • 1. Pharmacokinetics and pharmacodynamics of the antiarrhythmic compound MD750819 in dogs with experimentally induced arrhythmias.
    Dow J; Laquais B; Tisne-Versailles J; Pourrias B; Benedetti MS
    J Pharmacokinet Biopharm; 1982 Jun; 10(3):283-96. PubMed ID: 7175700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic analysis of changrolin in dogs with arrhythmia.
    Liu CX; Gu YB; Feng JL; Wei GL; Xiao SH; Sun JL
    Yao Xue Xue Bao; 1996; 31(9):666-70. PubMed ID: 9863232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cibenzoline in patients with renal impairment.
    Canal M; Flouvat B; Aubert P; Guedon J; Prinseau J; Baglin A
    J Clin Pharmacol; 1985 Apr; 25(3):197-203. PubMed ID: 3998200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of pharmacokinetics for antiarrhythmic drugs.
    Harrison DC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():65-72. PubMed ID: 6803703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propafenone disposition kinetics in cardiac arrhythmia.
    Connolly S; Lebsack C; Winkle RA; Harrison DC; Kates RE
    Clin Pharmacol Ther; 1984 Aug; 36(2):163-8. PubMed ID: 6744775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic plasma concentrations of NIK-244 on canine ventricular arrhythmias.
    Hashimoto K; Matsuzaki T; Haruno A
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):892-8. PubMed ID: 2481779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and pharmacodynamics of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog].
    Kaverina NV; Rodionov AP; Lyskovzev VV; Grigoreva JK; Sulakvelidze MT; Poppe H; Klemm W; Morgenroth U
    Pharmazie; 1985 Dec; 40(12):869-70. PubMed ID: 3841607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and efficacy of pirmenol hydrochloride in the treatment of ventricular dysrhythmia.
    Lee TG; Goldberg AD; Chang T; Serkland MT; Yakatan GJ; Johnson EL; Toole JG; Goldstein S
    J Cardiovasc Pharmacol; 1983; 5(4):632-7. PubMed ID: 6193362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and antiarrhythmic effect of lorcainide.
    Klotz U; Müller-Seydlitz P; Heimburg P
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):152-8. PubMed ID: 376458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacology of the new combined anti-arrhythmia preparation metatsizin].
    Kaverina NV; Chichkanov GG; Bugriĭ EM; Vititnova MB; Tolmacheva EA; Turilova AI; Kryzhanovskiĭ SA; Lyskovtsev VV; Rodionov AP; Beloborodov VL
    Eksp Klin Farmakol; 1998; 61(2):33-6. PubMed ID: 9621171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA; Vincent AC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of a newly synthesized compound (711389-S) on various types of experimentally induced arrhythmias in mammalian species in situ.
    Kadowaki Y; Ohta T; Hotokebuchi N; Kimoto S; Haruna M; Nakao T; Ueda M; Nishi K
    Jpn J Pharmacol; 1988 Apr; 46(4):359-72. PubMed ID: 3404766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological correction of myocardial ischemia and arrhythmias in reversible coronary blood flow disorders and experimental myocardial infarct in dogs].
    Gorbunov NP; Sukhanov AA; Bolotova MF
    Kardiologiia; 1980 May; 20(5):84-7. PubMed ID: 7392390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
    Klotz U; Müller-Seydlitz P; Heimburg P
    Clin Pharmacokinet; 1978; 3(5):407-18. PubMed ID: 699462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, nicainoprol, on canine ventricular arrhythmias.
    Hashimoto K; Akiyama K; Mitsuhashi H
    Jpn J Pharmacol; 1989 Feb; 49(2):245-54. PubMed ID: 2733262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic and pharmacodynamic analysis of a class IC antiarrhythmic, pilsicainide, in patients with cardiac arrhythmias.
    Ogawa R; Kishi R; Mihara K; Takahashi H; Takagi A; Matsumoto N; Masuhara K; Nakazawa K; Miyake F; Kobayashi S; Echizen H
    J Clin Pharmacol; 2006 Jan; 46(1):59-68. PubMed ID: 16397285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.
    Allen JD; Ekue JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1972 Aug; 45(4):561-73. PubMed ID: 5085230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anti-arrhythmia properties of bonnecor metabolites].
    Grigor'eva EK; Poppe H; Tolmacheva EA; Krasnykh LM
    Farmakol Toksikol; 1990; 53(3):48-50. PubMed ID: 2387382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia.
    Vegh A; Györgyi K; Papp JG; Sakai K; Parratt JR
    Eur J Pharmacol; 1996 Jun; 305(1-3):163-8. PubMed ID: 8813547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.